Comprehensive Meta-Analysis of Safety and Efficacy of Bivalirudin Versus Heparin With or Without Routine Glycoprotein IIb/IIIa Inhibitors in Patients With Acute Coronary Syndrome-Reference-Cited by-同舟云学术

Comprehensive Meta-Analysis of Safety and Efficacy of Bivalirudin Versus Heparin With or Without Routine Glycoprotein IIb/IIIa Inhibitors in Patients With Acute Coronary Syndrome

Published:2015-01 Issue:1 Volume:8 Page:201-213
ISSN:1936-8798
Container-title:JACC: Cardiovascular Interventions
language:en
Short-container-title:JACC: Cardiovascular Interventions

Author:

Navarese Eliano Pio,Schulze Volker,Andreotti Felicita,Kowalewski Mariusz,Kołodziejczak Michalina,Kandzari David E.,Rassaf Tienush,Gorny Bartosz,Brockmeyer Maximilian,Meyer Christian,Berti Sergio,Kubica Jacek,Kelm Malte,Valgimigli Marco

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference31 articles.

1. 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines;O'Gara;J Am Coll Cardiol,2013

2. ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC)

3. Bleeding risk and outcomes of Bivalirudin versus Glycoprotein IIb/IIIa inhibitors with targeted low-dose unfractionated Heparin in patients having percutaneous coronary intervention for either stable or unstable angina pectoris;Steinberg;Am J Cardiol,2008

4. Low-molecular-weight heparins vs. unfractionated heparin in the setting of percutaneous coronary intervention for ST-elevation myocardial infarction: a meta-analysis;Navarese;J Thromb Haemost,2011

5. Unfractionated heparin versus bivalirudin in primary percutaneous coronary intervention (HEAT-PPCI): an open-label, single centre, randomised controlled trial;Shahzad;Lancet,2014

Cited by 69 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The year in cardiovascular medicine 2023: the top 10 papers in thrombosis and antithrombotic treatment;European Heart Journal;2024-03-15

2. Periprocedural antithrombotic strategies in acute coronary syndromes undergoing percutaneous coronary intervention: Have we discarded bivalirudin too soon?;Cardiovascular Revascularization Medicine;2023-12

3. Outcomes of same‐day discharge following percutaneous coronary intervention in a rural population;Catheterization and Cardiovascular Interventions;2023-07-22

4. Bivalirudin plus a high-dose infusion versus heparin in patients with acute coronary syndrome;European Heart Journal - Cardiovascular Pharmacotherapy;2023-04-20

5. Acute Coronary Syndrome in the Older Adult Populations;Contemporary Cardiology;2023